Advertisement

Annals of Surgical Oncology

, Volume 24, Issue 10, pp 2827–2835 | Cite as

Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema, Recommendations from an Expert Panel: Part 2: Preventive and Therapeutic Options

  • Sarah A. McLaughlinEmail author
  • Sarah M. DeSnyder
  • Suzanne Klimberg
  • Michael Alatriste
  • Francesco Boccardo
  • Mark L. Smith
  • Alicia C. Staley
  • Paul T. R. Thiruchelvam
  • Nancy A. Hutchison
  • Jane Mendez
  • Fiona MacNeill
  • Frank Vicini
  • Stanley G. Rockson
  • Sheldon M. Feldman
Breast Oncology

The American Society of Breast Surgeons (ASBrS) recognizes lymphedema as a significant side effect of breast cancer treatment. Therefore, the ASBrS convened an international, multidisciplinary expert panel to review current data and guidelines on all aspects of lymphedema diagnosis and management to acknowledge the gravity of this public health issue facing breast cancer survivors. The Panel sought to collate clear and meaningful recommendations for providers regarding lymphedema diagnosis, treatment, and prevention. Diagnosis, education, and future directions were discussed in Part 1. Part 2 focuses on prevention and treatment.

Risk-Reducing Behaviors

Given the study disagreements concerning risk factors and definitions of breast cancer-related lymphedema (BCRL), it is not surprising that clinicians have difficulty accurately predicting who will experience the development of BCRL. To prevent lymphedema, clinicians continue to recommend risk-reducing behaviors (RRB) that have largely...

Notes

Acknowledgment

This work was funded via an unrestricted educational grant from ImpediMed.

Conflict of interest

Frank Vicini is a research adviser for ImpediMed. There are no other conflicts of interest.

References

  1. 1.
    McLaughlin SA, et al. Trends in risk reduction practices for the prevention of lymphedema in the first 12 months after breast cancer surgery. J Am Coll Surg. 2013;216(3):380–9.Google Scholar
  2. 2.
    McLaughlin SA, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors. J Clin Oncol. 2008;26:5220–6.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Showalter SL, et al. Lifestyle risk factors associated with arm swelling among women with breast cancer. Ann Surg Oncol. 2013;20:842–9.CrossRefPubMedGoogle Scholar
  4. 4.
    Kilbreath SL, et al. Risk factors for lymphoedema in women with breast cancer: a large prospective cohort. Breast. 2016;28:29–36.CrossRefPubMedGoogle Scholar
  5. 5.
    Ferguson, CM, et al. Impact of ipsilateral blood draws, injections, blood pressure measurements, and air travel on the risk of lymphedema for patients treated for breast cancer. J Clin Oncol. 2016;34:691–8.CrossRefPubMedGoogle Scholar
  6. 6.
    The diagnosis and treatment of peripheral lymphedema: 2016 consensus document of the International Society of Lymphology. Lymphology. 2016;49:170–84.Google Scholar
  7. 7.
    Gerber LH. Cancer rehabilitation into the future. Cancer. 2001;92(4 Suppl):975–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Pinto BM, Maruyama NC. Exercise in the rehabilitation of breast cancer survivors. Psychooncology. 1999;8:191–206.CrossRefPubMedGoogle Scholar
  9. 9.
    Pinto BM, et al. Psychological and fitness changes associated with exercise participation among women with breast cancer. Psychooncology. 2003;12:118–26.CrossRefPubMedGoogle Scholar
  10. 10.
    Rock CL, Demark-Wahnefried W. Can lifestyle modification increase survival in women diagnosed with breast cancer? J Nutr. 2002;132(11 Suppl):3504S–7S.PubMedGoogle Scholar
  11. 11.
    Schmitz KH, et al. Weight-lifting in women with breast cancer-related lymphedema. N Engl J Med. 2009;361:664–73.CrossRefPubMedGoogle Scholar
  12. 12.
    Loudon A, et al. Yoga management of breast cancer-related lymphoedema: a randomised controlled pilot-trial. BMC Complement Alt Med. 2014;14:214.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Di Blasio A, et al. Physical exercises for breast cancer survivors: effects of 10 weeks of training on upper limb circumferences. J Phys Ther Sci. 2016;28:2778–84.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Courneya KS, et al. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol. 2007;25:4396–404.CrossRefPubMedGoogle Scholar
  15. 15.
    Hayes SC, Reul-Hirche H, Turner J. Exercise and secondary lymphedema: safety, potential benefits, and research issues. Med Sci Sports Exer. 2009;41:483–9.CrossRefPubMedGoogle Scholar
  16. 16.
    Portela AL, et al. Feasibility of an exercise program for Puerto Rican women who are breast cancer survivors. Rehab Oncol. 2008;26:20–31.PubMedPubMedCentralGoogle Scholar
  17. 17.
    Exercise for Lymphedema Patients (Internet). National Lymphedema Network, Berkeley, CA. http://www.lymphnet.org/pdfDocs/position.papers/Exercise.pdf (2011). Accessed 6 Feb 2017.
  18. 18.
    Lymphedema (Internet). American Cancer Society, Atlanta, GA. https://www.cancer.org/treatment/treatments-and-side-effects/physical-side-effects/lymphedema.html (2017). Accessed 6 Feb 2017
  19. 19.
    Lymphedema (Internet). Susan G. Komen, Dallas, TX (2017). Accessed 6 February 2017.Google Scholar
  20. 20.
    National Comprehensive Cancer Network (NCCN) Guideline Version 2.2016. http://www.nccn.org/professionals/physician_gls/pdf/breast-screening.pdf (2016). Accessed 23 Jan 2017
  21. 21.
    Brown JC, Troxel AB, Schmitz KH. Safety of weightlifting among women with or at risk for breast cancer-related lymphedema: musculoskeletal injuries and health care use in a weightlifting rehabilitation trial. Oncologist. 2012;17:1120–8.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Ahmed M, et al. Systematic review of axillary reverse mapping in breast cancer. Br J Surg. 2016;103:170–8.CrossRefPubMedGoogle Scholar
  23. 23.
    Beek MA, et al. Axillary reverse mapping in axillary surgery for breast cancer: an update of the current status. Breast Cancer Res Treat. 2016;158:421–32.CrossRefPubMedGoogle Scholar
  24. 24.
    Boneti C, et al. Axillary reverse mapping (ARM): initial results of phase II trial in preventing lymphedema after lymphadenectomy. Minerva Ginecol. 2012;64:421–30.PubMedGoogle Scholar
  25. 25.
    Boneti C, et al. Scientific Impact Award: axillary reverse mapping (ARM) to identify and protect lymphatics draining the arm during axillary lymphadenectomy. Am J Surg. 2009;198:482–7.CrossRefPubMedGoogle Scholar
  26. 26.
    Gebruers N, Tjalma WA. Clinical feasibility of axillary reverse mapping and its influence on breast cancer-related lymphedema: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2016;200:117–22.CrossRefPubMedGoogle Scholar
  27. 27.
    Han C, et al. The feasibility and oncological safety of axillary reverse mapping in patients with breast cancer: a systematic review and meta-analysis of prospective studies. PloS One. 2016;11:e0150285.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Noguchi M, et al. Feasibility study of axillary reverse mapping for patients with clinically node-negative breast cancer. Eur J Surg Oncol. 2016;42:650–6.CrossRefPubMedGoogle Scholar
  29. 29.
    Ochoa D, et al. Axillary reverse mapping: five-year experience. Surgery. 2014;156:1261–8.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Tummel E, et al. Does axillary reverse mapping prevent lymphedema after lymphadenectomy? Ann Surg. 2017;265:987–92.CrossRefPubMedGoogle Scholar
  31. 31.
    Yue T, et al. A prospective study to assess the feasibility of axillary reverse mapping and evaluate its effect on preventing lymphedema in breast cancer patients. Clin Breast Cancer. 2015;15:301–6.CrossRefPubMedGoogle Scholar
  32. 32.
    Boccardo F, et al. Lymphedema microsurgical preventive healing approach: a new technique for primary prevention of arm lymphedema after mastectomy. Ann Surg Oncol. 2009;16:703–8.CrossRefPubMedGoogle Scholar
  33. 33.
    Boccardo FM, et al. Surgical prevention of arm lymphedema after breast cancer treatment. Ann Surg Oncol. 2011;18:2500–5.CrossRefPubMedGoogle Scholar
  34. 34.
    Boccardo F, et al. Lymphatic microsurgical preventing healing approach (LYMPHA) for primary surgical prevention of breast cancer-related lymphedema: over 4 years follow-up. Microsurgery. 2014;34:421–4.CrossRefPubMedGoogle Scholar
  35. 35.
    Feldman S, et al. Single-institution experience with lymphatic microsurgical preventive healing approach (LYMPHA) for the primary prevention of lymphedema. Ann Surg Oncol. 2015;22:3296–301.CrossRefPubMedGoogle Scholar
  36. 36.
    Gomberawalla A, VJ, Borden B, Rohde C, Ascherman J, Taback B, et al. Lymphatic microsurgical preventive healing approach (LYMPHA) for the primary prevention of lymphedema. In: Poster presentation 39th Annual San Antonio Breast Cancer Symposium P2-01-14; 2016.Google Scholar
  37. 37.
    Position Statement of the National Lymphedema Network. The diagnosis and treatment of lymphedema, NLN Medical Advisory Committee 2011. http://www.lymphnet.org/pdfDocs/nlntreatment.pdf. Accessed 15 Feb 2017.
  38. 38.
    Szolnoky G, Dobozy A, Kemeny L. Towards an effective management of chronic lymphedema. Clin Dermatol. 2014;32:685–91.CrossRefPubMedGoogle Scholar
  39. 39.
    Wanchai A, Armer JM, Stewart BR, Lasinski BB Breast cancer-related lymphedema: a literature review for clinical practice. Int J Nurs Sci. 2016;3:202–7.Google Scholar
  40. 40.
    Randheer S, et al. Comprehensive decongestive therapy in postmastectomy lymphedema: an Indian perspective. Indian J Cancer. 2011;48:397–402.CrossRefPubMedGoogle Scholar
  41. 41.
    Position Statement of the National Lymphedema Network. Lymphedema risk reduction practices 2012. http://www.lymphnet.org/pdfDocs/nlnriskreduction.pdf (2017). Accessed 15 February 15 2017.
  42. 42.
    Smile TD, et al. A review of treatment for breast cancer-related lymphedema: paradigms for clinical practice. Am J Clin Oncol. 2016. DOI:  10.1097/COC.0000000000000355 PubMedGoogle Scholar
  43. 43.
    Lasinski BB, et al. A systematic review of the evidence for complete decongestive therapy in the treatment of lymphedema from 2004 to 2011. PM R J Injury Function Rehabil. 2012;4:580–601.Google Scholar
  44. 44.
    Feldman JL, et al. Intermittent pneumatic compression therapy: a systematic review. Lymphology. 2012;45:13–25.PubMedGoogle Scholar
  45. 45.
    Rodrick JR, et al. Complementary, alternative, and other noncomplete decongestive therapy treatment methods in the management of lymphedema: a systematic search and review. PM R J Injury Function Rehabil. 2014;6:250–74; quiz 274Google Scholar
  46. 46.
    Masia J, Pons G, Nardulli ML. Combined surgical treatment in breast cancer-related lymphedema. J Reconstr Microsurg. 2016;32:16–27.CrossRefPubMedGoogle Scholar
  47. 47.
    Feldman MG, et al. Lymphangiographic studies in obstructive lymphedema of the upper extremity. Surgery. 1966;59:935–43.PubMedGoogle Scholar
  48. 48.
    Yoo JN, et al. Validity of quantitative lymphoscintigraphy as a lymphedema assessment tool for patients with breast cancer. Ann Rehabil Med. 2015;39:931–40.CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Hwang JH, et al. Lymphscintigraphy predicts response to complex physical therapy in patients with early stage extremity lymphedema. Lymphology. 2007;40:172–6.PubMedGoogle Scholar
  50. 50.
    Stanton AW, et al. Forearm blood flow measured by venous occlusion plethysmography in healthy subjects and in women with postmastectomy oedema. Vasc Med. 1998;3:3–8.CrossRefPubMedGoogle Scholar
  51. 51.
    Mihara M, et al. Indocyanine green (ICG) lymphography is superior to lymphoscintigraphy for diagnostic imaging of early lymphedema of the upper limbs. PloS One. 2012;7:e38182.CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Vaughan BF. CT of swollen legs. Clin Radiol. 1990;41:24–30.CrossRefPubMedGoogle Scholar
  53. 53.
    Boccardo F, et al. Lymphatic microsurgery to treat lymphedema: techniques and indications for better results. Ann Plast Surg. 2013;71:191–5.CrossRefPubMedGoogle Scholar
  54. 54.
    Mihara M, et al. Upper-limb lymphedema treated aesthetically with lymphaticovenous anastomosis using indocyanine green lymphography and noncontact vein visualization. J Reconstr Microsurg. 2012;28:327–32.CrossRefPubMedGoogle Scholar
  55. 55.
    Becker C. Autologous lymph node transfers. J Reconstr Microsurg. 2016;32:28–33.PubMedGoogle Scholar
  56. 56.
    Baumeister RG, et al. Microsurgical lymphatic vessel transplantation. J Reconstr Microsurg. 2016;32:34–41.PubMedGoogle Scholar
  57. 57.
    Campisi C, Boccardo F. Microsurgical techniques for lymphedema treatment: derivative lymphatic-venous microsurgery. World J Surg. 2004;28:609–13.CrossRefPubMedGoogle Scholar
  58. 58.
    Maclellan RA, Greene AK. Lymphedema. Semin Pediatr Surg. 2014;23:191–7.CrossRefPubMedGoogle Scholar
  59. 59.
    Loh CY, et al. The 5th World Symposium for Lymphedema Surgery: recent updates in lymphedema surgery and setting up of a global knowledge exchange platform. J Surg Oncol. 2017;115:6–12.CrossRefPubMedGoogle Scholar
  60. 60.
    Yamamoto T, et al. Indocyanine green-enhanced lymphography for upper extremity lymphedema: a novel severity staging system using dermal backflow patterns. Plast Reconstr Surg. 2011;128:941–7.CrossRefPubMedGoogle Scholar
  61. 61.
    Yamamoto T, et al. Characteristic indocyanine green lymphography findings in lower extremity lymphedema: the generation of a novel lymphedema severity staging system using dermal backflow patterns. Plast Reconstr Surg. 2011;127:1979–86.CrossRefPubMedGoogle Scholar
  62. 62.
    Becker C, et al. Postmastectomy lymphedema: long-term results following microsurgical lymph node transplantation. Ann Surg. 2006;243:313–5.CrossRefPubMedPubMedCentralGoogle Scholar
  63. 63.
    Tobbia, D, et al. Lymphedema development and lymphatic function following lymph node excision in sheep. J Vasc Res. 2009;46:426–34.CrossRefPubMedGoogle Scholar
  64. 64.
    Slavin SA, et al. Return of lymphatic function after flap transfer for acute lymphedema. Ann Surg. 1999;229:421–7.CrossRefPubMedPubMedCentralGoogle Scholar
  65. 65.
    Slavin SA, et al. An investigation of lymphatic function following free-tissue transfer. Plast Reconstr Surg. 1997;99:730–41; discussion 742–3CrossRefPubMedGoogle Scholar
  66. 66.
    Adair TH, et al. Quantitation of changes in lymph protein concentration during lymph node transit. Am J Physiol. 1982;243:H351–9.PubMedGoogle Scholar
  67. 67.
    Adair TH, Guyton AC. Modification of lymph by lymph nodes: II. Effect of increased lymph node venous blood pressure. Am J Physiol. 1983;245:H616–22.PubMedGoogle Scholar
  68. 68.
    Adair TH, Guyton AC. Modification of lymph by lymph nodes: III. Effect of increased lymph hydrostatic pressure. Am J Physiol. 1985; 249(4): H777–82.PubMedGoogle Scholar
  69. 69.
    Ito R, et al. Proposed pathway and mechanism of vascularized lymph node flaps. Gynecol Oncol. 2016;141:182–8.CrossRefPubMedGoogle Scholar
  70. 70.
    Miranda Garces M, et al. A comprehensive review of the natural lymphaticovenous communications and their role in lymphedema surgery. J Surg Oncol. 2016;113:374–80.CrossRefPubMedGoogle Scholar
  71. 71.
    Edwards JM, Kinmonth JB. Lymphovenous shunts in man. Br Med J. 1969;4:579–81.CrossRefPubMedPubMedCentralGoogle Scholar
  72. 72.
    Huang JJ, et al. Lymph node transplantation decreases swelling and restores immune responses in a transgenic model of lymphedema. PloS One. 2016;11:e0168259.CrossRefPubMedPubMedCentralGoogle Scholar
  73. 73.
    Lahteenvuo M, et al. Growth factor therapy and autologous lymph node transfer in lymphedema. Circulation. 2011;123:613–20.CrossRefPubMedGoogle Scholar
  74. 74.
    Viitanen TP, et al. Lymphatic vessel function and lymphatic growth factor secretion after microvascular lymph node transfer in lymphedema patients. Plast Reconstr Surg Global Open. 2013;1:1–9.CrossRefPubMedPubMedCentralGoogle Scholar
  75. 75.
    Skobe M, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nature Med. 2001;7:192–8.CrossRefPubMedGoogle Scholar
  76. 76.
    Dayan JH, et al. The use of magnetic resonance angiography in vascularized groin lymph node transfer: an anatomic study. J Reconstr Microsurg. 2014;30:41–5.CrossRefPubMedGoogle Scholar
  77. 77.
    Dayan JH, Dayan E, Smith ML. Reverse lymphatic mapping: a new technique for maximizing safety in vascularized lymph node transfer. Plast Reconstr Surg. 2015;135:277–85.CrossRefPubMedGoogle Scholar
  78. 78.
    Chowdhry MRW, Griffiths M. Lymphatic mapping and preoperative imaging in the management of postmastectomy lymphoedema. Gland Surg. 2016;5:187–96.PubMedPubMedCentralGoogle Scholar
  79. 79.
    Mardonado AA, Chen R, Chang DW. The use of supraclavicular free flap with vascularized lymph node transfer for treatment of lymphedema: a prospective study of 100 consecutive cases. J Surg Oncol. 2017;115:68–71.CrossRefPubMedGoogle Scholar
  80. 80.
    Lee M, et al. Lymphedema of the upper extremity following supraclavicular lymph node harvest. Plast Reconstr Surg. 2015;135:1079e–82e.CrossRefPubMedPubMedCentralGoogle Scholar
  81. 81.
    Nguyen AT, Suami H. Laparoscopic free omental lymphatic flap for the treatment of lymphedema. Plast Reconstr Surg. 2015;136:114–8.CrossRefPubMedGoogle Scholar
  82. 82.
    Cheng MH, et al. A novel approach to the treatment of lower extremity lymphedema by transferring a vascularized submental lymph node flap to the ankle. Gynecol Oncol. 2012;126:93–8.CrossRefPubMedGoogle Scholar
  83. 83.
    Coriddi M, Skoracki R, Eiferman D. Vascularized jejunal mesenteric lymph node transfer for treatment of extremity lymphedema. Microsurgery. 2017;37:177–8.CrossRefPubMedGoogle Scholar
  84. 84.
    Smith ML, et al. Heterotopic vascularized lymph node transfer to the medial calf without a skin paddle for restoration of lymphatic function: proof of concept. J Surg Oncol. 2017;115:90–5.CrossRefPubMedGoogle Scholar
  85. 85.
    Granzow JW, Soderberg JM, Dauphine C. A novel two-stage surgical approach to treat chronic lymphedema. Breast J., 2014;20:420–2.CrossRefPubMedGoogle Scholar
  86. 86.
    Brorson H. Complete reduction of arm lymphedema following breast cancer: a prospective twenty-one years’ study. Plast Reconstr Surg. 2015;136(4 Suppl):134–5.CrossRefPubMedGoogle Scholar
  87. 87.
    Campisi CC, et al. Fibro-lipo-lymph-aspiration with a lymph vessel-sparing procedure to treat advanced lymphedema after multiple lymphatic-venous anastomoses: the complete treatment protocol. Ann Plast Surg. 2017. 78(2):184–190.CrossRefPubMedGoogle Scholar
  88. 88.
    Brorson H, Svensson H. Liposuction combined with controlled compression therapy reduces arm lymphedema more effectively than controlled compression therapy alone. Plast Reconstr Surg. 1998;102:1058–67; discussion 1068.CrossRefPubMedGoogle Scholar
  89. 89.
    Casley-Smith JR. Lymphedema initiated by aircraft flights. Aviat Space Environ Med. 1996;67:52–6.PubMedGoogle Scholar
  90. 90.
    Graham PH. Compression prophylaxis may increase the potential for flight-associated lymphoedema after breast cancer treatment. Breast. 2002;11:66–71.CrossRefPubMedGoogle Scholar
  91. 91.
    Kilbreath SL, et al. Effect of air travel on lymphedema risk in women with history of breast cancer. Breast Cancer Res Treat. 2010;120:649–54.CrossRefPubMedGoogle Scholar
  92. 92.
    Clark B, Sitzia J, Harlow W. Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study. QJM. 2005;98:343–8.CrossRefPubMedGoogle Scholar
  93. 93.
    Dawson WJ, et al. Elective hand surgery in the breast cancer patient with prior ipsilateral axillary dissection. Ann Surg Oncol. 1995;2:132–7.CrossRefPubMedGoogle Scholar
  94. 94.
    Gharbaoui I, Netscher DT, Thornby J, et al. Safety of upper extremity surgery after prior treatment for ipsilateral breast cancer: results of an American Society for Surgery of the Hand membership survey and literature review. J Am Society Surg Hand. 2005; 5(4):232-238.CrossRefGoogle Scholar
  95. 95.
    Hershko DD, Stahl S. Safety of elective hand surgery following axillary lymph node dissection for breast cancer. Breast J. 2007;13:287–90.CrossRefPubMedGoogle Scholar
  96. 96.
    Ahmed RL, et al. Randomized controlled trial of weight-training and lymphedema in breast cancer survivors. J Clin Oncol. 2006;24:2765–72.CrossRefPubMedGoogle Scholar
  97. 97.
    Sagen A, Karesen R, Risberg MA. Physical activity for the affected limb and arm lymphedema after breast cancer surgery: a prospective, randomized controlled trial with two years follow-up. Acta Oncol. 2009;48:1102–10.CrossRefPubMedGoogle Scholar
  98. 98.
    Schmitz KH, et al. Weight-lifting for women at risk for breast cancer-related lymphedema: a randomized trial. JAMA. 2010;304:2699–705.CrossRefPubMedGoogle Scholar
  99. 99.
    Kilbreath SL, et al. Progressive resistance training and stretching following surgery for breast cancer: study protocol for a randomised controlled trial. BMC Cancer. 2006;6:273.CrossRefPubMedPubMedCentralGoogle Scholar
  100. 100.
    Johansson K, et al. Low-intensity resistance exercise for breast cancer patients with arm lymphedema with or without compression sleeve. Lymphology. 2005;38:167–80.PubMedGoogle Scholar
  101. 101.
    McKenzie DC, Kalda AL. Effect of upper extremity exercise on secondary lymphedema in breast cancer patients: a pilot study. J Clin Oncol. 2003;21:463–6.CrossRefPubMedGoogle Scholar
  102. 102.
    Kim DS, et al. Effect of active resistive exercise on breast cancer-related lymphedema: a randomized controlled trial. Arch Phys Med Rehabil. 2010;91:1844–8.CrossRefPubMedGoogle Scholar

Copyright information

© Society of Surgical Oncology 2017

Authors and Affiliations

  • Sarah A. McLaughlin
    • 1
    Email author
  • Sarah M. DeSnyder
    • 2
  • Suzanne Klimberg
    • 3
  • Michael Alatriste
    • 4
  • Francesco Boccardo
    • 5
  • Mark L. Smith
    • 6
    • 7
  • Alicia C. Staley
    • 8
  • Paul T. R. Thiruchelvam
    • 9
  • Nancy A. Hutchison
    • 10
  • Jane Mendez
    • 11
  • Fiona MacNeill
    • 12
  • Frank Vicini
    • 13
  • Stanley G. Rockson
    • 14
    • 15
  • Sheldon M. Feldman
    • 16
  1. 1.Department of SurgeryMayo ClinicJacksonvilleUSA
  2. 2.Department of Breast Surgical OncologyThe University of Texas MD AndersonCancer CenterHoustonUSA
  3. 3.Department of Breast and Surgical OncologyWinthrop P. Rockefeller Cancer InstituteLittle RockUSA
  4. 4.Lymphedema Alliance of New YorkNew YorkUSA
  5. 5.Department of SurgeryUnit of Lymphatic Surgery - S. Martino University Hospital, University of GenoaGenoaItaly
  6. 6.Department of SurgeryNorthwell HealthLake SuccessUSA
  7. 7.Reconstructive OncologyNorthwell Health Cancer InstituteLake SuccessUSA
  8. 8.Akari HealthBostonUSA
  9. 9.Imperial College HealthcareLondonUK
  10. 10.Courage Kenny Rehabilitation Institute of AllinaHealthMinneapolisUSA
  11. 11.Miami Cancer InstituteMiamiUSA
  12. 12.Association of Breast Surgery Great Britain and IrelandRoyal College of Surgeons of EnglandLondonUK
  13. 13.Radiation OncologyUCLA School of MedicineLos AngelesUSA
  14. 14.Center for Lymphatic and Venous DisordersStanford University School of MedicineStanfordUSA
  15. 15.Lymphatic Research and BiologyFalk Cardiovascular Research CenterStanfordUSA
  16. 16.Division of Breast Surgery and Breast Surgical Oncology, Montefiore Medical Center, The University Hospital for the Albert Einstein College of MedicineMontefiore Einstein Center for Cancer CareNew YorkUSA

Personalised recommendations